http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-2018005703-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
filingDate 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba45fd0699e4638140e490099c269d2
publicationDate 2018-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SV-2018005703-A
titleOfInvention (S) - 5- (5- (2- (3-AMINOPROPOXI) -6-METOXYPHENYL) -1H-PIRAZOL-3-ILAMINO) PIRAZINE-2-CARBONITRILE MONOHIDRATE
abstract THE PRESENT INVENTION REFERS TO MONOHIDRATE OF (S) - LACTATE OF 5- (5- (2- (3-AMINOPROPOXI) -6-METOXIFENIL) -1H-PIRAZOL-3-ILAMINO) PIRAZIN-2-CARBONITRILE THAT INHIBITS CHK1 / 2 AND IT IS USEFUL IN CANCER TREATMENT
priorityDate 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559042

Total number of triples: 19.